Related Experiment Video
Updated: Mar 13, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Discharge medication complexity and 30-day heart failure readmissions
A Carmine Colavecchia1, David R Putney1, Michael L Johnson2
1Houston Methodist Hospital, Department of Pharmacy, 6565 Fannin St., DB1-09, Houston, TX 77030, United States.
High medication regimen complexity, measured by the computerized Medication Regimen Complexity Index (MRCI), is linked to increased 30-day hospital readmissions for heart failure patients. This tool can help identify at-risk individuals for targeted medication therapy management.
Area of Science:
- Pharmacoeconomics
- Clinical Pharmacy
- Health Services Research
Background:
- Limited research exists on the Medication Regimen Complexity Index (MRCI) and its effectiveness in predicting hospital readmissions.
- Identifying patients at high risk for readmission is crucial for optimizing healthcare resource allocation and improving patient outcomes.
Purpose of the Study:
- To evaluate the association between discharge MRCI scores and 30-day rehospitalization rates in heart failure (HF) patients.
- To determine the utility of a computerized MRCI scoring system in identifying patients at risk for HF readmission.
Main Methods:
- Retrospective cohort study using data from a large tertiary teaching facility (University HealthSystem Consortium) from January 2011 to December 2013.
- Identified HF patients and analyzed 30-day readmissions. Compared manual and computerized MRCI scoring methods.
- Multivariable logistic regression analyzed the association between a computerized MRCI score (≥15) and 30-day readmission, controlling for other variables.
Main Results:
- A total of 1,452 HF patients were included; 5.9% were readmitted within 30 days.
- The computerized MRCI moderately correlated with the manual MRCI (R=0.74, R²=0.55).
- A computerized MRCI score of 15 or higher was significantly associated with a 1.62-fold increased odds of 30-day readmission (OR: 1.62; 95% CI: 1.01-2.59). Patients on ACE inhibitors/ARBs were less likely to be readmitted, while those with coronary artery disease were more likely.
Conclusions:
- A computerized MRCI score demonstrated a significant association with 30-day heart failure readmissions.
- The computerized MRCI system shows potential as a predictive tool for identifying high-risk patients.
- Pharmacists can utilize such tools for targeted medication therapy management to improve patient outcomes and reduce readmissions.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure Drugs: Diuretics
Heart Failure VI: Adjunct Therapies

